您好,欢迎访问三七文档
当前位置:首页 > 商业/管理/HR > 经营企划 > 巴陵公司己内酰胺产品竞争战略研究
湖南大学硕士学位论文巴陵公司己内酰胺产品竞争战略研究姓名:高明申请学位级别:硕士专业:工商管理指导教师:单汨源20041001WTO,IAbstractBalingPetro-chemicalCompanyisoneofthegreatestcaprolactamproducersinChina.AfterchinaenteredWTO,thiscompanyisnowfacingtwotremendouschallenges:Oneisthethreatofcompetitionfromcaprolactammarketoutsidethecompany.Betweendomesticandoverseaslargecaprolactamcompany,thecompetitionismoresevereinaspectsofcost,technology,priceandmarketing;Theotheristhehiddendangerofmanagementinsidethecompany.Forthisreason,itisnecessarythatthecompanyconstructitscompetitivecorecapabilityassoonaspossibletoinsureitssustainablecompetitiveadvantage.Thispaperusedtheproductioncompetitionstrategyandtherelativetheories,inviewofproblemsexistinginthecompany’sproductionandmanagement,accordingtothebaseofdocumentsconsultingandthefactinvestigation,frominner&outerenvironmentofcaprolactamcompetition,analysedthecompanyfromtwoaspects,oneiscompetitivestrategymethod,adoptingqualityanalysismethodandtheothermethodistoadoptquantityanalysismethod,foundtheadvantageanddisadvantage,thechallengeandopportunityintheouterenvironmentofthecaprolactamcompetition.Accordingtoanalysisresult,webringforwardastrategiccompetitionplanforBalingCompany,andaimatthesituationofthestrategyexecution,putforwardthegranteeconditionofstrategyfromconstructingHSEsystem,enforcingnetconstruction,improvingmanagementenvironmentandmanpowerresource.Theexecutionofthecompetitionstrategycansolvetheproblemsexistinginthecompany’sproductionandmanagement,conformtheresourceslogical,exerttheadvantageandseizethechance.Itcanhelpthecompanystepoutthedifficultsituationatanearlydate,realizethemanagegoalandestablishthecompetitivecorecapabilityofcaprolactamproduction,insureitssustainablecompetitiveadvantage.So,asoneofthebiggestcaprolactamproducersinChina,Balingcompanycansustainanycompetitionpressureandturnthepressuretomotivityandrealizeacontinuableimprovementunderthedrasticcompetitionofcaprolactammarket.Keyword:BalingPetro-chemicalCompanyCaprolactamCompetitivestrategyII1______21.143.12002(%)173.219972011CPL204.1CPL294.2CPL33III2.182.2102.3CPL113.1CPL143.2CPL163.3CPL183.41997-2011CPL194.1CPL304.2CPL324.3CPL34IV11.11.1.11.1.1.120005343400110017167601.31.1.1.2CPL47060504.5kt/a,184.5kt60%CPL10%CPLCPLWTOCPL11.1.21.21.2.11.2.1.1[1][2]2[3]1.2.1.2[4]1.2.1.3[5][5][5]31.2.1.4[6][7]A.A.J.[8]1.14---[9][10][11][9]1.2.2PESTSWOTPEST[12]5[13]SWOT[14]SWOT[15]1.2.31.31.3.1PESTSWOT1.3.2162722.12.1.119907199295/1997DSMHPODCS9098199~200072.12.1///2000700006900012400200170000710009500200270000720001080020037000068000126002000-20032.1.22000200120022003404548552330323710%20033753%[17]20018500/8CPL2001127CPL200362.120%80%2.1.320027200050%144%93%2000200220016802003200290010%1997140%CPL9CPL[16]20002003340058314.6%2003700095002.9%5.2%20026256.17%2000-20032.2//200070000690008.8-1800200170000710009.0-3000200270000720009.4-6200200370000680008.6-84002000-20032.1.4539.5,452.1.4.120002.1.4.22.1.4.31020002.1.4.42.22.2.12.2.298BASFDSM2.3CPL/tBASFDSM1457148415401392140014392002112.2.32000200218.5%8%2.2.42.2.5WTO20011233.13.1.1CPLCPL33%CPLCPLCPL10%CPL[18]98CPL2001127CPL200366CPL528[19]CPLCPLCCPLCPLWTO3.1CPL3.1.2WTOCPL13WTOCPL1.6CPL3.1CPL20012002200320042005200629337100CPL12.510.8939081010PA61612.811.810.79.7540231906149.87.45540232906139.77.35550110006179.87.4561513.311.7102001.4WTO66CPL[20]2.CPLCPL,200271,CPL,CPLCPL,WTO3.WTOCPLPA666CPLCPL14CPL4.6CPLCPLPA66CPLCPL3.23.2.13.2.1.1CPLCPLCPL66CPL2010CPL204050%CPL3.23.219984127kt/a,20024589kt/a2.6%15.4%19983390kt/a,20023992kt/a4.6%10.03%20065%20023.219984127kt/a,20024589kt/a2.6%15.4%1519983390kt/a,20023992kt/a4.6%10.03%20065%3.120023.2CPLkt%19981999200020012002200620111998-20022002-20062006-20115795865965965965965960.8005195815995775925585831-0.70.9308319354338342356366110.65415666877477761186159515.411.756.95275016316897401055140717.3410.626.67(122813291519152116581910226810.035.123.7510731090110011101110126013602.92.41.6932949101310421047115011904.320.77377117547487738218943.31.61.79339439439439439489480.20.1051254556860167464569861.41.62582443233593413654196.80.32.88939229629619551037114731.5278881383580584794510690.53.32.57727728047337738869970.023.92.41091171171171171171476.304.776898784921071302.35.1480879190981131210.74.61.441274223440544734589514457842.62.82.433543480373237983992446050774.33.32.633903470385437983992446050784.63.32.6WTO20032004.03.19CPL25%675%647%30%23%CPL61650%CPL[21]0510152025303540453.12002(%)3.2.1.2CPL199710%5.13.8%20011521kt40.1%CPL830ktCPL96%3.33.3CPLCPLCPL1/36CPLCPLCPLCPL3.2.2CPL47060504.5kt/a,184.5kt140120kt/a17CPL3.43.3CPLkt(%)19981999200020012002200620111996-20022002-20062006-20111151251751751753454459.314.65.212011316415816731539916.114.84.830334742144346956473017.94.95.3-183-234-257-285-302-249-3311141141141141442343847.315.510.41151151171201201952408.410.24.2305358361320385410438-0.65.11.3-190-243-244-200-265-215-19811012518518524529544517.43.88.612311917522523525538016.72.58.33463564414354545236499.13.83.4-223-237-266-210-219-268-2391321321321321321821821.96.601089197106125170175-0.99.90.611593991
本文标题:巴陵公司己内酰胺产品竞争战略研究
链接地址:https://www.777doc.com/doc-618475 .html